MedPath

广州仁恒医药科技股份有限公司

Ownership
-
Established
2013-04-07
Employees
-
Market Cap
-
Website
www.renheng.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Vitamin B₁₂ Eye Drops

Product Name
维生素B₁₂滴眼液
Approval Number
国药准字H20253705
Approval Date
Mar 25, 2025
NMPA

Pranoprofen Eye Drops

Product Name
普拉洛芬滴眼液
Approval Number
国药准字H20244176
Approval Date
Jun 28, 2024
NMPA

Moxifloxacin Hydrochloride Eye Drops

Product Name
盐酸莫西沙星滴眼液
Approval Number
国药准字H20243794
Approval Date
May 21, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.